We have shown that the killing phenotype relies on direct cell‐to‐cell interaction between the target tumor organoids and the immune cells and was observed despite the absence of CD80 and CD86 costimulatory molecules, which is in line with previous reports [8, 12, 13]. The gene discussed is CD86; the disease is neoplasm.